Invention Grant
- Patent Title: Heterocyclic compounds as RSV inhibitors
-
Application No.: US16100721Application Date: 2018-08-10
-
Publication No.: US10759816B2Publication Date: 2020-09-01
- Inventor: Jianming Yu , Brian C. Shook , Thomas P. Blaisdell , In Jong Kim , Joseph Panarese , Kevin McGrath , Solymar Negretti-Emmanuelli , Yat Sun Or
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07D519/00
- IPC: C07D519/00 ; C07D495/04 ; C07D491/048 ; C07D513/04 ; C07D498/04 ; C07D401/06 ; C07D401/14 ; C07D487/04 ; A61K31/55 ; A61K31/551 ; A61K31/553 ; A61K31/554 ; A61K45/06
Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20190040084A1 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS Public/Granted day:2019-02-07
Information query
